Crossmark

Neuroprotective efficacy of berberine and caffeine against rotenone‐induced neuroinflammatory and oxidative disturbances associated with Parkinson’s disease via inhibiting α-synuclein aggregation and boosting dopamine release

Crossref DOI link: https://doi.org/10.1007/s10787-025-01661-w

Published Online: 2025-03-09

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Waheeb, Tasnim S. https://orcid.org/0009-0005-5988-6883
Abdulkader, Mohammad A.

Ghareeb, Doaa A.

Moustafa, Mohamed E.
Funding

Funding for this research was provided by:

Alexandria University
License Information

Text and Data Mining valid from 2025-03-09

Version of Record valid from 2025-03-09
More Information

Article History

Received: 26 December 2024

Accepted: 12 January 2025

First Online: 9 March 2025

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

: This study was conducted in compliance with the protocols of the Declaration of Alexandria University and approved by the Ethics Committee of Faculty of Science, Alexandria University, Egypt (approval number AU 04191123101).

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below